WallStreetZenWallStreetZen

NASDAQ: SAGE
Sage Therapeutics Inc Stock Ownership - Who owns Sage Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Sage Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kimi IguchiCFO Treasurer2024-01-021,642$1.36
$2.23kBuy
Anne Marie CookSVP GC Secretary2023-11-281,174$19.27
$22.62kSell
Kimi IguchiCFO Treasurer2023-11-28943$19.27
$18.17kSell
Jeffrey M. JonasDirector2023-11-283,935$19.27
$75.83kSell
Elizabeth BarrettDirector2023-08-092,000$18.64
$37.28kBuy
Elizabeth BarrettDirector2023-05-091,000$50.50
$50.50kBuy

1 of 1

SAGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SAGE insiders and whales buy or sell their stock.

SAGE Shareholders

What type of owners hold Sage Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Steven M. Paul12.37%7,432,477$99.07MInsider
Biogen Inc10.38%6,241,473$83.20MInsider
Wellington Management Group LLP10.09%6,061,996$80.81MInstitution
Fmr LLC9.12%5,482,477$73.08MInstitution
Robert Nelsen9.12%5,482,038$73.08MInsider
Vanguard Group Inc8.85%5,319,360$70.91MInstitution
Rtw Investments LP8.65%5,197,019$69.28MInstitution
Blackrock Inc7.76%4,663,900$62.17MInstitution
State Street Corp6.52%3,918,222$52.23MInstitution
Bellevue Group Ag5.85%3,513,351$46.83MInstitution

1 of 3

SAGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SAGE71.61%28.39%Net Selling
TNGX59.42%40.58%Net BuyingNet Selling
RLAY72.36%27.64%Net SellingNet Selling
PLRX70.74%29.26%Net Selling
SPRY43.85%56.15%Net BuyingNet Buying
View Top Biotech Stocks

Sage Therapeutics Stock Ownership FAQ

Who owns Sage Therapeutics?

Sage Therapeutics (NASDAQ: SAGE) is owned by 93.30% institutional shareholders, 36.98% Sage Therapeutics insiders, and 0.00% retail investors. Steven M. Paul is the largest individual Sage Therapeutics shareholder, owning 7.43M shares representing 12.37% of the company. Steven M. Paul's Sage Therapeutics shares are currently valued at $95.80M.

If you're new to stock investing, here's how to buy Sage Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.